From "ECM ingredients cosmetics" to "extracellular matrix skincare," the search and filing trends in overseas skincare markets over the past two years have been highly consistent: the focus of ingredient-savvy consumers is shifting from single active substances (niacinamide, retinol) to the formulation logic of the "entire extracellular matrix (ECM) microenvironment." To understand this wave, we must first answer a question—why does cosmetics need "ECM thinking"?
I. Why Does Cosmetics Need "ECM Thinking"?
The dermis of the skin is the main arena of the ECM: type I collagen (accounting for over 80% of the dry weight of the dermis), type III collagen, elastin, glycosaminoglycan (GAG, represented by hyaluronic acid), proteoglycan, and structural glycoproteins such as fibronectin and laminin. Fibroblasts "live" within this three-dimensional network—the ECM is not just a scaffold; it also continuously sends mechanical and biochemical signals to cells through receptors such as integrins, regulating cell proliferation, migration, and synthesis behavior. The essence of photoaging and natural aging is precisely the decline in ECM synthesis rate, increased activity of matrix metalloproteinases (MMPs), and accumulation of oxidative stress, leading to collagen fragmentation, GAG loss, and loss of skin support and resilience.
This is the answer to the skincare pyramid: barrier (cleansing, moisturizing, sun protection) → moisturizing → repair → anti-aging, progressing upward level by level, with the top levels increasingly relying on formulation strategies that "target the ECM." The significance of topical ECM ingredients is not to "stuff collagen into the skin," but to mimic or supplement the composition and signal fragments of the dermal ECM, inducing the skin to initiate its self-repair program.
Specifically at the formulation end, "ECM thinking" has three actionable levers: First, upgrade moisturizing from "surface hydration" to "mimicking GAG water absorption"—using multi-molecular-weight HA and proteoglycan to build a hydration gradient from the stratum corneum to the dermis; Second, upgrade repair from "soothing and calming" to "supporting fibroblast function"—using collagen peptides and signal peptides to provide cells with recognizable synthesis instructions; Third, upgrade anti-aging from "anti-free radicals" to "anti-ECM degradation"—by inhibiting MMP activity and supplementing ECM signal fragments, delaying the net loss of collagen and elastin. These three levers correspond exactly to the moisturizing, repair, and anti-aging layers of the pyramid, and are also the true positioning logic of ECM ingredients in formulations.
II. Inventory of Topical Ingredients: Analysis of Six Core Ingredients
1. Collagen and recombinant collagen peptides. Intact collagen has a molecular weight of about 300,000 Daltons (~300 kDa), far exceeding the penetration threshold of the stratum corneum (generally considered to be easily permeable below 500 Da). Therefore, the true role of topical intact collagen is film-forming moisturization and sensory modification; the ones truly responsible for "penetration and signaling" are hydrolyzed collagen peptides and recombinant collagen peptides—with molecular weights typically in the range of several hundred to several thousand Daltons. Some small-molecule recombinant humanized collagen fragments can claim transdermal absorption and promote collagen synthesis, which is also the core selling point of the two product lines "collagen peptide skincare" and "recombinant collagen skincare." Formulation roles: moisturizing, film-forming, soothing, and supporting ingredients for anti-wrinkle/firming claims. Note the data standards: permeability must be based on experimental evidence such as in vitro Franz diffusion cells, and "transdermal" should not be claimed lightly.
2. Hyaluronic acid and hydrolyzed hyaluronic acid. HA is a typical multi-molecular-weight system: large molecules (>1000 kDa) form a film on the surface to lock in water, medium molecules (100–1000 kDa) provide mid-layer moisturization, and small molecules and oligomeric HA (<10 kDa, i.e., hydrolyzed hyaluronic acid) have better permeability and can interact with CD44 receptors in the skin. The formulation trend is multi-molecular-weight combinations—large molecules for immediate sensory feel, small molecules for deep hydration, which is also why "hydrolyzed hyaluronic acid" appears frequently in functional products. A reminder: low-molecular-weight HA also has pro-angiogenic and pro-inflammatory signaling aspects (concentration-dependent), so the added amount must be restrained to avoid conflict with "soothing" claims.
3. Elastin peptides. Elastin gives skin resilience, but its cross-linked structure is dense and extremely difficult to dissolve. Ingredients mostly exist in the form of hydrolyzed elastin/elastin peptides, with mechanisms leaning toward "elastic fiber signal mimicry + moisturizing." Combined with collagen peptides, they form the "elastic network" concept, used for firming and elasticity claims.
4. Proteoglycan. Core protein + glycosaminoglycan side chains (chondroitin sulfate, dermatan sulfate, etc.), it is a dual-function molecule in the dermis that combines water absorption and signaling beyond HA. Claims follow a high-end route of "deep moisturizing + ECM repair." High cost and large batch variation, mostly seen in high-end serum lines.
5. Signal peptides (Matrixyl type). Represented by palmitoyl oligopeptide (Matrixyl) and palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7 (Matrixyl 3000), they are matrikine-mimicking peptides: mimicking the signal fragments produced by ECM degradation, transmitting the instruction "time to repair" to fibroblasts, stimulating type I and type III collagen and HA synthesis. The mechanism is "signal rather than filling," requiring continuous use for 4–8 weeks to observe effects. They are classic core ingredients in anti-wrinkle/firming serums.
6. dECM micropowder/extract. Decellularized ECM (dECM) micropowder retains the three-dimensional structure and composite active components of natural ECM (collagen + GAG + growth factor remnants), claiming "biomimetic microenvironment, promoting repair." The advantage is comprehensive signaling, closer to physiological state; the difficulty lies in decellularization processes, batch stability, and microbial control. High cost, mostly used in medical device dressings or high-end functional lines.
III. Formulation Logic: From "Water-Oil Balance" to "ECM-Mimicking Cocktail"
Water-oil balance addresses sensory and barrier issues, while the ECM-mimicking cocktail addresses efficacy signaling. The two are layered relationships, not replacements. A typical ECM-mimicking combination is "collagen peptides + multi-molecular-weight HA + signal peptides": small-molecule HA improves stratum corneum hydration and opens moisturizing pathways, recombinant collagen peptides provide ECM structural fragment signals, and Matrixyl-type peptides directly stimulate fibroblasts to synthesize collagen—the three signaling pathways are complementary. In transdermal technology, nano-liposome/phospholipid vesicle encapsulation can improve the stability and penetration efficiency of small-molecule peptides; soluble microneedles can deliver ECM peptides directly to the upper dermis; supramolecular technology (such as cyclodextrin inclusion) improves the dissolution and sustained release of poorly soluble actives. What formulators truly need to control is "signal strength": excessive small-molecule HA or free peptides may trigger inflammatory signals, and rhythm and dosage are often more important than concentration.
IV. Efficacy Evaluation and Claim Compliance
China's "Cosmetics Efficacy Claim Evaluation Regulations" implement classified management of claims: claims such as spot whitening, sun protection, anti-hair loss, anti-acne, repair, nourishing, anti-wrinkle, and firming require human efficacy evaluation tests, consumer use tests, laboratory tests, or literature according to evidence levels. ECM products claiming "repair/anti-wrinkle/firming" must have corresponding evidence documents; claims of "transdermal absorption" and "promoting collagen synthesis" require penetration experiments and cell experiment support. Compliance boundaries must be clear: medical device registration (Class II medical device medical dressings) is managed under medical device registration, expressed with indication language (such as wound healing, post-operative repair), and does not follow the cosmetics claim system; cosmetic products are strictly prohibited from medical claims ("regeneration, tissue repair, treatment" are all forbidden zones). Safe wording for ECM ingredients is scientific expressions like "maintaining ECM microenvironment homeostasis" and "supporting the skin's own collagen synthesis," rather than medical semantic words like "rebuilding/regenerating ECM."
V. B2B Perspective: How Brands Choose Ingredients and OEM
When choosing ingredients, look at four things: purity (SDS-PAGE, SEC-HPLC determination of purity and molecular weight distribution), activity (cell experiments measuring collagen synthesis promotion ability, hydroxyproline content), stability (thermal stability, batch consistency, shelf life), and regulatory document package (COA, MSDS, efficacy data, toxicological safety data, ingredient safety information submission code). When choosing OEM, look at qualification depth: factories that can simultaneously undertake cosmetic product and medical device dressing OEM (such as Class II medical device medical mask OEM) allow brands to package "daily care line + post-operative repair line" into the same supply chain—Weitai Group's zhenmeifu has this dual-track OEM capability. For small and medium brands, it is recommended to start with a combination of "cosmetic compound serum + medical device dressing": medical device registration builds professional trust, cosmetics drive volume and repeat purchases.
VI. One-Sentence Conclusion
ECM is not just another "concept ingredient," but a fundamental target that pushes cosmetic efficacy from superficial efforts to the skin's self-repair—whoever first establishes the formulation and evidence system of "ECM thinking" will hold the product discourse power for the next five years.
Appendix: Overview of Common ECM Ingredients in Cosmetics
| Ingredient | Source | Mechanism | Common Molecular Weight | Claim Direction |
|---|---|---|---|---|
| Collagen | Animal source (bovine/fish skin, etc.) | Film-forming moisturizing, sensory modification | ~300 kDa | Moisturizing, elasticity |
| Hydrolyzed collagen peptides | Animal source hydrolysis | Moisturizing, mild penetration, signal mimicry | ~500–3000 Da | Moisturizing, anti-wrinkle |
| Recombinant collagen peptides | Microbial fermentation (humanized sequence) | Structural fragment signaling, promoting collagen synthesis | Tens of thousands to hundreds of thousands Da (small fragments down to hundreds Da) | Repair, anti-wrinkle, firming |
| Hyaluronic acid | Microbial fermentation/animal source | Water absorption and locking, space filling | >1000 kDa (large molecule) | Moisturizing, plumping |
| Hydrolyzed hyaluronic acid | HA enzymatic hydrolysis | Penetration, receptor interaction | <10 kDa (oligomeric) | Deep moisturizing, repair |
| Elastin peptides | Animal source hydrolysis | Elastic signaling, moisturizing | Thousands Da level | Firming, elasticity |
| Proteoglycan | Animal cartilage, etc. extraction | Dual function of water absorption + signaling | Hundreds of thousands Da level | Deep moisturizing, ECM repair |
| Signal peptides (Matrixyl type) | Chemical synthesis | Matrikine signaling, stimulating collagen synthesis | Hundreds to 1000 Da level | Anti-wrinkle, firming |
| dECM micropowder/extract | Animal tissue decellularization | Biomimetic microenvironment, composite signaling | Micron-sized particles/mixture | Repair, post-medical aesthetics |
Further Reading: To learn more about one-stop OEM services for cosmetics and medical aesthetics, please visit Zhenmeifu; for collagen and ECM ingredient supply, please visit Velubio.
